Search clinical trials for: ticagrelor ASA

Total 2598 results

Peking University Third Hospital
AstraZeneca Investment (China) Co., Ltd

Completed

Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke

Cerebrovascular Accident | Cerebrovascular Accident, Acute

China
Medical University of Vienna

Completed

Antithrombotic Triple Therapy in Humans

Atrial Fibrillation | Acute Coronary Syndrome

Austria
Vastra Gotaland Region
Uppsala University; Gothia Forum - Center for Clinical Trial

Recruiting

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome (TACSI)

Acute Coronary Syndrome

Denmark, Sweden, Norway, Finland, Iceland
Assiut University

Unknown

Early Versus Late Loading of Ticagrelol in Patients With STEMI

Myocardial Infarction
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Medical University of Vienna

Completed

Triple vs. Dual Therapy

Atrial Fibrillation | Acute Coronary Syndrome

Austria
Centro Cardiologico Monzino
IRCCS National Neurological Institute "C. Mondino" Foundation

Recruiting

Antiplatelet Therapies in Patients With Depression and Coronary Disease (ENHANCE)

Depression | Coronary Artery Disease

Italy
Maasstad Hospital
Medtronic

Completed

Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI (DAPT-STEMI)

Myocardial Infarction | Cardiovascular Disease

Norway, Netherlands, Poland, Switzerland
University of Athens

Completed

A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI (PTOLEMAIOS)

Aortic Valve Stenosis

Greece
Collegium Medicum w Bydgoszczy

Completed

Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study

Unstable Angina Pectoris

Poland
Federico II University
AdvicePharma Group

Completed

Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS (PlinytheElder)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | STEMI | NSTEMI

Italy
University of Florida

Completed

High Ticagrelor Loading Dose in STEMI

Coronary Artery Disease

United States
Barretos Cancer Hospital

Completed

Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment

Actinic Keratosis

Brazil
Federal State Budgetary Institution, V. A. Almazov...

Recruiting

Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia

Intracranial Aneurysm

Russian Federation
AstraZeneca
Parexel

Completed

A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Sickle Cell Disease

Germany
Juan J Badimon
AstraZeneca

Completed

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Coronary Artery Disease | Type-2 Diabetes Mellitus

United States
Ira Winer

Recruiting

ASk Questions in GYnecologic Oncology (ASQ-GYO) (ASQ-GYO)

Cervical Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Gestational Trophoblastic Disease

United States
University of Split, School of Medicine
Clinical Hospital Centre Zagreb

Unknown

Influence of HFNO on Spontaneous Ventilation in Patients of Different ASA Risk During Analgo-sedation for Vitrectomy

Hypoxia | Respiratory Insufficiency | Airway Management | Vitrectomy | Noninvasive Ventilation | Moderate Sedation

Croatia
Icahn School of Medicine at Mount Sinai
AstraZeneca

Completed

Reversing Ticagrelor's Effects With Fresh Platelets

Coronary Artery Disease

United States
Nanjing Medical University

Completed

Does American Society of Anesthesiologists (ASA) Physical Status Scale Enough in Patients Assessment (ASAINPA)

Elective Surgery

China
University of Florida
AstraZeneca

Completed

Impact of Ticagrelor Re-load on Pharmacodynamic Profiles

Coronary Artery Disease

United States
Arkansas Heart Hospital
University of Alabama at Birmingham; The University of Texas Health Science...

Terminated

Ticagrelor and Peripheral Arterial Disease

Peripheral Arterial Disease

United States
University of Florida
The Medicines Company

Completed

In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients

Coronary Artery Disease

United States
David Antoniucci
AstraZeneca; A.R. CARD Onlus Foundation

Completed

Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy, Greece
Centro Hospitalario La Concepcion

Recruiting

Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome (TICA-MASTICA)

Acute Coronary Syndrome

Mexico
Sheba Medical Center

Completed

Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients

ST Elevation Myocardial Infarction | Acute Coronary Syndromes

Israel
Prof. Dr. Cemil Tascıoglu Education and Research...

Completed

Mortality Predictions With Scorring Indices in Gastrointestinal Tumours

Gastrointestinal Tumours

Turkey
Cairo University

Completed

Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence

Cardiovascular Diseases | Acute Coronary Syndrome

Egypt
Weill Medical College of Cornell University
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

One-Month DAPT in CABG Patients (ODIN)

Chronic Coronary Disease

United States, Austria, Canada, Germany, Sweden
Juan Badimon

Completed

Platelet Sub-study of the TWILIGHT Trial

Myocardial Infarction | Coronary Artery Disease

United States
AstraZeneca

Completed

Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.

Bioavailability Heathy Volunteers

United Kingdom
AstraZeneca

Completed

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

Myocardial Infarction | Stroke | Atherothrombosis | Cardiovascular Death

Sweden, United States, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Peru, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Philippines, China, Hungary, Romania, U... and more
AstraZeneca

Completed

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS)

Diabetes Mellitus, Type 2

United States, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Spain, United Kingdom, Czechia, Hungary, Thailand, Turkey, Vietnam, Korea, Republic of, Brazil, Peru, Philippines, Poland, China, Japan, Taiwan, Hong... and more
University of Karachi
PharmEvo Private Limited., Pakistan

Completed

Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition (BE)

Healthy Individuals

Pakistan
University of Patras

Completed

OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study) (LIQUID)

ST Elevation Myocardial Infarction

Greece
Azienda Ospedaliero Universitaria di Sassari
AstraZeneca

Completed

Ticagrelor Administered as Standard Tablet or Orodispersible Formulation (TASTER)

ST Elevation Myocardial Infarction | NSTEMI - Non-ST Segment Elevation MI

Italy
AstraZeneca

Completed

Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets

Inhibition on Platelet Aggregation

United States
The Cleveland Clinic
AstraZeneca

Terminated

Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery (INTREPID)

Myocardial Injury

United States
Bio-innova Co., Ltd

Not yet recruiting

Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg (TIC-025-23)

Healthy Subjects
First Affiliated Hospital of Harbin Medical University

Unknown

Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI

Acute Coronary Syndrome

China
University Magna Graecia

Completed

Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor (SHIFT-OVER)

Acute Coronary Syndrome

Italy
Dong-A University

Recruiting

Ticagrelor De-escalation Strategy in East Asian Patients With AMI

Acute Myocardial Infarction

Korea, Republic of
The Third Xiangya Hospital of Central South University

Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Coronary Heart Disease

China
University Hospital, Toulouse

Completed

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement (TIRATROP)

Atherosclerosis

France
Massachusetts General Hospital
AstraZeneca

Withdrawn

Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study

Coronary Artery Disease | Acute Coronary Syndrome

United States
First Affiliated Hospital of Harbin Medical University

Unknown

Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS

Non ST Segment Elevation Acute Coronary Syndrome

United States
Icahn School of Medicine at Mount Sinai

Completed

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

Type 2 Diabetes | Peripheral Artery Disease

United States
AstraZeneca

Completed

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] (SOCRATES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Sweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
AstraZeneca

Completed

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease (HESTIA 1)

Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease

United States, Canada, United Kingdom, South Africa, Lebanon, Kenya

Search clinical trials for: ticagrelor ASA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations